ArticleFrontiers in public health2020

Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China.

Liudan Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.